ロード中...
Cobimetinib- and vemurafenib-induced granulomatous dermatitis and erythema induratum: A case report
Metastatic melanoma is an aggressive malignancy. Survival can be increased with the combination of BRAF and MEK inhibition. BRAF inhibitor-induced cutaneous toxicities can be attenuated with MEK inhibition. Here, we describe the first reported case of a patient with metastatic melanoma who developed...
保存先:
| 出版年: | SAGE Open Med Case Rep |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6537058/ https://ncbi.nlm.nih.gov/pubmed/31205706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X19847358 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|